Dog EEG for wake-promotion studies.

Area of Science:

• Pharmacology
• Neuroscience
• Animal Models

Background:

• Assessing the efficacy of novel compounds for wake promotion is crucial in drug discovery.
• Traditional methods for monitoring sleep-wake states in animals can be invasive and introduce bias.
• Development of non-invasive, reliable methods is needed for preclinical drug evaluation.

Purpose of the Study:

• To describe a novel protocol for evaluating the wake-promoting activity of new chemical entities (NCEs) in dogs.
• To demonstrate the utility of this protocol using a known wake-promoting agent, modafinil.

Main Methods:

• Utilizing a polygraphic recording system with telemetry devices in four implanted beagles.
• Recording of electromyography (EMG) and cortical electroencephalography (EEG) signals in non-tethered animals.
• Scoring of sleep and wake stages to assess the impact of NCEs.

Main Results:

• The described protocol allows for reliable assessment of sleep/wake dynamics in dogs.
• Data obtained using this method are comparable to existing literature for modafinil.
• The non-tethered approach minimizes potential bias and complications associated with conventional systems.

Conclusions:

• This protocol offers a robust and unbiased method for investigating wake-promoting drug candidates.
• The technique is suitable for preclinical screening of NCEs targeting sleep-wake disorders.
• Further application of this method can accelerate the development of novel therapeutics for promoting wakefulness.